Skip to content

Clinical trials

Alzheimer Disease trials in Canada with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Unknown status Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20082
20131
20141
20161
20182
20192
20201
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto3
McMaster University2
Sunnybrook Health Sciences Centre2
Bellus Health Inc. - a GSK company1
Bio Conscious Technologies Inc.1
Bruyère Health Research Institute.1
GAAD Medical Research Institute Inc.1
New York State Institute for Basic Research1
University of British Columbia1
University of Calgary1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease15
Dementia9
Cognitive Dysfunction6
Parkinson Disease2
Plaque, Amyloid2
Dementia, Vascular1
Down Syndrome1
Frontotemporal Lobar Degeneration1
Inflammation1
Lewy Body Disease1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.